A population pharmacokinetic model for mycophenolic acid and metabolites in kidney transplant recipients.

被引：0
|
作者：
Akhlaghi, Fatemeh [1 ]
Sam, Wei J. [1 ]
Rosenbaum, Sara E. [1 ]
机构：
[1] Univ Rhode Isl, Kingston, RI 02881 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2007年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1174
引用
收藏
页码：448 / 448
页数：1
相关论文
共 50 条
  • [1] Pharmacokinetics of mycophenolic acid and metabolites in diabetic kidney transplant recipients
    Akhlaghi, F
    Patel, CG
    Zuniga, XP
    Halilovic, D
    Preis, IS
    Gohh, RY
    THERAPEUTIC DRUG MONITORING, 2006, 28 (01) : 95 - 101
  • [2] Population Pharmacokinetics of Mycophenolic Acid and Its 2 Glucuronidated Metabolites in Kidney Transplant Recipients
    Sam, Wai-Johnn
    Akhlaghi, Fatemeh
    Rosenbaum, Sara E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (02): : 185 - 195
  • [3] Clinical Significance of Mycophenolic Acid Therapeutic Drug Monitoring in Kidney Transplant Recipients.
    Kim, C. -D.
    Cho, J. -H.
    Kim, K.
    Kim, M.
    Do, W.
    Yang, Y.
    Yim, T.
    Hwang, I.
    Lee, J. -H.
    Jung, H. -Y.
    Choi, J. -Y.
    Park, S. -H.
    Kim, Y. -L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 784 - 784
  • [4] Population Pharmacokinetics of Mycophenolic Acid and its Metabolites in Liver Transplant Recipients
    Li, Yangbing
    Chen, Bing
    Wang, Xiao-Xing
    Chen, Hao
    Feng, Meihua R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S79 - S79
  • [5] Population pharmacokinetic modeling for mycophenolic acid and its main glucuronide metabolite in Chinese kidney transplant recipients
    YANG Chun-lan
    SHENG Chang-cheng
    FENG Li-juan
    JIAO Zheng
    XU Du-juan
    中国药理学与毒理学杂志, 2019, (10) : 817 - 817
  • [6] Mycophenolic acid pharmacokinetics in paediatric liver transplant recipients.
    Aw, MM
    Brown, N
    Tredger, M
    Mieli-Vergani, G
    Dhawan, A
    HEPATOLOGY, 2001, 34 (04) : 292A - 292A
  • [7] Variability of mycophenolic acid elimination in the renal transplant recipients - population pharmacokinetic approach
    Velickovic-Radovanovic, Radmila M.
    Jankovic, Slobodan M.
    Milovanovic, Jasmina R.
    Catic-Dordevic, Aleksandra K.
    Spasic, Ana A.
    Stefanovic, Nikola Z.
    Dzodic, Predrag Lj.
    Smelcerovic, Andrija A.
    Cvetkovic, Tatjana P.
    RENAL FAILURE, 2015, 37 (04) : 652 - 658
  • [8] Concentration of total mycophenolic acid (MPA), mycophenolic acid glucuronide (MPAG) and unbound MPA in diabetic kidney transplant recipients.
    Akhlaghi, F
    Patel, CG
    Zuinga, P
    Lin, S
    Yango, A
    Gohh, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 232 - 232
  • [9] The Effect of Tacrolimus and Mycophenolic Acid on Torque Teno Virus Loads in Kidney Transplant Recipients.
    van Rijn, A.
    Meziyerh, S.
    van der Helm, D.
    van Gelder, T.
    Kroes, A.
    de Fijter, J.
    Moes, D.
    Rotmans, J.
    de Vries, A.
    Feltkamp, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 1030 - 1030
  • [10] Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study
    Martin-Moreno, Paloma L.
    Sanchez-Fructuoso, Ana, I
    Mazuecos, Auxiliadora
    Mir, Marisa
    Lopez-Lopez, Isabel
    Gonzalez-Rinne, Ana
    Coca, Armando
    Valero, Rosalia
    Ventura Galiano, Ana
    Ridao, Natalia
    Toapanta-Gaibor, Nestor G.
    Fernandez-Tagarro, Ernesto
    Cruzado-Vega, Leonidas
    Perez-Mir, Monica
    Jimenez, Carlos
    CLINICAL TRANSPLANTATION, 2021, 35 (05)
12345